Experts discuss updated findings presented at the 2024 EHA Congress in diseases such as mantle cell lymphoma and acute myeloid leukemia.
Manali Kamdar, MD
Advertisement
Articles by Manali Kamdar, MD
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Revumenib in R/R NPM1-Mutant AML
2
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
3
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
